# US 2012/0252014 A1 · Method of normalized quantification of nucleic acids using anchor oligonucleotides and adapter oligonucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252014 A1
- Document ID: US20120252014A1
- Status: Published application
- Kind: A1
- Application number: 13/388,224
- Filed: 2010-07-30
- Published: 2012-10-04
- Earliest claimed: 2009-07-31
- Assignees: Qiagen GmbH
- Inventors: Dirk Loeffert; Christian Korfhage; Holger Engel
- Web page: https://patentgrep.com/patent/US20120252014A1

## CPC

- C12Q 1/6851: Quantitative amplification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention is related to normalized quantification of nucleic acids and to the normalization of quantities of nucleic acids in samples, e.g. mixtures of nucleic acids. The present invention relates to method for the normalization of the quantity of a nucleic acid to be quantified in a sample to the total quantity of nucleic acid in the sample; or to the total quantity of a specific class of nucleic acid in the sample.

## Claims

### Claim 1

Method for the normalization of the quantity of a nucleic acid to be quantified in a sample to
(i) the total quantity of nucleic acid in the sample; or to
(ii) the total quantity of a specific class of nucleic acid in the sample,
comprising the steps of
(a) providing a sample containing a nucleic acid to be quantified,
(b) adding a first nucleic acid probe to the sample under conditions allowing for hybridization of at least a terminal region of said first nucleic acid probe to specific binding sites of nucleic acid in the sample such that double-stranded nucleic acids are created. Wherein said first nucleic acid probe comprises at least one primer binding site, a probe binding site, and an anchor oligonucleotide binding site;
(c) adding an anchor oligonucleotide under conditions allowing for hybridization to the anchor oligonucleotide binding site of the first nucleic acid probe so that a 5′sequence of the anchor oligonucleotide is not hybridized to the first nucleic acid probe;
(d) elongating the nucleic acid at its 3′end, wherein said first nucleic acid probe serves as template until the region is reached where said anchor oligonucleotide is hybridized to the first nucleic acid probe whereon the anchor oligonucleotide serves as a template for further elongation;
(e) quantifying the total amount of nucleic acid in the sample or the total amount of the specific class of nucleic acid in the sample using a second probe substantially complementary to a region of the DNA transcribed from said first nucleic acid probe and anchor oligonucleotide;
f) quantifying the nucleic acid to be quantified using optionally a third probe whose sequence is substantially identical to a defined region of the nucleic acid to be quantified; and
(g) normalizing the quantity of the nucleic acid to be quantified by determining the ratio of the quantity of the nucleic acid to be quantified to the total quantity of nucleic acid in the sample or the total quantity of the specific class of nucleic acid in the sample,

### Claim 2 (depends on 1)

The method according to claim 1, wherein the nucleic acid to be quantified is RNA and the specific class of nucleic acid is RNA.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the RNA to he quantified is RNA selected from the group consisting of mRNA, rRNA, tRNA, nRNA, siRNA, snRNA, snoRNA, scaRNA, microRNA, dsRNA, ribozyme, riboswitch and viral RNA and wherein the total quantity of RNA is selected from the group consisting of the total quantity of RNA, the total quantity of mRNA, the total quantity of rRNA, the total quantity of tRNA, the total quantity of nRNA, the total quantity of siRNA, the total quantity of snRNA, the total quantity of snoRNA, the total quantity of scaRNA, the total quantity of microRNA, the total quantity of dsRNA, the total quantity of ribozyme, the total quantity of riboswitch, the total quantity of viral RNA.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the RNA to he quantified is mRNA and the specific class of nucleic acid is mRNA.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the specific binding site is a poly-A sequence or a poly-A tail.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the nucleic acid to be quantified is DNA and the specific class of nucleic acid is DNA.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the DNA to be quantified is DNA selected from the group consisting of cDNA, dsDNA, ssDNA, plasmid DNA, cosmid DNA, chromosomal DNA, viral DNA and mtDNA and wherein the total quantity of DNA is selected from the group consisting of the total quantity of DNA, the total quantity of cDNA, the total quantity of dsDNA, the total quantity of ssDNA, the total quantity of plasmid DNA, the total quantity of cosmid DNA, the total quantity of chromosomal DNA, the total quantity of viral DNA and the total quantity of mtDNA.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the DNA to be quantified is cDNA and the specific class of nucleic acid is cDNA.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the specific binding site is specific for cDNA or is a poly-T sequence or a poly-T tail.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the first nucleic acid probe is DNA or RNA,

### Claim 11 (depends on 1)

The method according to claim 1, wherein quantification comprises quantitative real-time PCR.

### Claim 12 (depends on 2)

The method according to claim 2, additionally comprising a step of contacting the RNA in the sample with a reverse transcriptase under conditions allowing for the reverse transcription of RNA or the specific class of RNA in the sample.

### Claim 13 (depends on 5)

The method according to claim 5, wherein said first nucleic acid probe hybridizes in such a fashion to said specific binding site that it is positioned at or close to the 5′ end of said poly-A sequence or poly-A tail.

### Claim 14 (depends on 1)

The method according to claim 1, wherein quantification comprises quantitative real-time PCR.

### Claim 15 (depends on 2)

The method according to claim 2, additionally comprising a step of contacting the RNA in the sample with a reverse transcriptase subsequent to the ligation step under conditions allowing for the reverse transcription of RNA or the specific class of RNA in the sample,

### Claim 16 (depends on 15)

The method according to claim 15, wherein the quantification comprises quantitative real-time reverse transcription PCR.

### Claim 17 (depends on 15)

The method according to claim 15, wherein reverse transcribing and quantifying are performed in the same reaction container.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the second and third nucleic acid probe are labelled with one or more fluorescent dye(s) and wherein the quantifying steps comprise detecting fluorescence signals in the sample.

### Claim 19 (depends on 1)

The method according to claim 1 for the normalization of gene expression levels.

### Claim 20 (depends on 1)

The method according to claim 1, wherein additionally a pre-quantified nucleic acid is added to the sample and wherein the quantity of said pre-quantified nucleic acid is determined in the quantifying steps.

### Claim 21 (depends on 1)

A kit for performing the method of claim 1, wherein the kit comprises;
(a) an adapter oligonucleotide substantially complementary to defined regions of nucleic acid or a specific class of nucleic acids in the sample, wherein the adapter oligonucleotide comprises one or more primer binding sites and a probe binding site and
(b) an anchor oligonucleotide substantially complementary to said probe binding site on said adapter oligonucleotide, wherein said anchor oligonucleotide comprises 5′ of the binding sequence to the adapter oligonucleotide a tag sequence.

### Claim 22 (depends on 1)

The use of the method of claim 1 for the normalization of the quantity of a specific nucleic acid to the quantity of a reference nucleic acid.

### Claim 23 (depends on 1)

The use of method of claim 1 for gene expression analysis.
